Hem › Äggstockscancer › Pennsylvania
Kliniska studier för Äggstockscancer i Pennsylvania
69 studier för Äggstockscancer söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Thomas Jefferson University Hospital, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC Altoona, Altoona
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- och 18 fler
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- och 2 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07059884A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
RekryterarFas 1
Ålder 19 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06586957Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- University of Pennsylvania, Philadelphia
Rekryterar
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05287451A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT05877599A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- St. Lukes University Hospital /ID# 274362, Bethlehem
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT06890338A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05128825Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05867251DESTINY-PANTUMOUR04
- Research Site, Philadelphia
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Kvinnor · Uppdaterad 24 sep. 2026 · NCT04590326A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213791A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
- Western Pennsylvania Gynecologic Oncology /ID# 278632, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 22 sep. 2026 · NCT07059845Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06128551Prehabilitation in High-risk Oncologic Surgery
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07638410BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT04752826A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 17 sep. 2026 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Pittsburgh Cancer Institute Cancer Services, Pittsburgh
- Allegheny Health Network- West Penn Hospital, Pittsburgh
- Lankenau Medical Center, Wynnewood
- och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 15 sep. 2026 · NCT07214779A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Penn State College of Medicine, Hershey
RekryterarFas 2
Ålder 18 till 99 · Kvinnor · Uppdaterad 15 sep. 2026 · NCT07023627ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh
- West Penn Hospital of Allegheny Health Network, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 14 sep. 2026 · NCT06787612FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Allegheny Singer, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06303505Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- St. Luke's University Health Network, Bethlehem
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 14 sep. 2026 · NCT04575935A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 sep. 2026 · NCT05123482A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Allegheny Health Network West Penn Hospital ( Site 0099), Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 3 sep. 2026 · NCT06824467FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT07216105Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- AHN West Penn Hospital, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 26 aug. 2026 · NCT05281471Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 1
Ålder 15 och äldre · Alla kön · Uppdaterad 25 aug. 2026 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
- UPMC, Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT06774963A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07470853A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07182149The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
- ACPMP, Springfield
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT07769346A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 12 aug. 2026 · NCT07546500A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Jefferson Abington Hospital, Abington
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Penn State Milton S Hershey Medical Center, Hershey
- och 15 fler
Rekryterar
Ålder 35 till 50 · Kvinnor · Uppdaterad 7 aug. 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Saint Luke's Cancer Center - Allentown, Allentown
- Saint Luke's University Hospital-Bethlehem Campus, Bethlehem
- och 21 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT06580314Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 4 aug. 2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT04657068Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.